Co-Diagnostics joint venture approved for HCV test in India

By LabPulse.com staff writers

April 19, 2022 -- Co-Diagnostics said its joint venture in India, CoSara Diagnostics, has received clearance to manufacture and sell its Saraq Hepatitis C (HCV) Viral Load Kit as an in vitro diagnostic.

Co-Diagnostics said its joint venture in India, CoSara Diagnostics, has received clearance to manufacture and sell its Saraq Hepatitis C (HCV) Viral Load Kit as an in vitro diagnostic.

The company said the PCR-based test is built on CoSara's CoPrimer technology and aids in assessing response to antiviral treatments in patients diagnosed with HCV, which has no effective vaccine.

The clearance was granted by India's Central Drugs Standard Control Organization.

Co-Diagnostics reports record revenue in 2021
Utah-based molecular diagnostics company Co-Diagnostics reported it achieved a record in annual revenue in 2021, primarily due to sales of its Logix Smart...
Co-Diagnostics to buy Idaho Molecular, Advanced Conceptions
Utah-based molecular diagnostics company Co-Diagnostics has entered a definitive agreement to acquire Idaho Molecular and Advanced Conceptions, two companies...
Fauci, health agencies confirm current PCR tests detect omicron
As the world grapples with yet another coronavirus variant -- this time omicron -- there is some good news. Companies and health agencies are attesting...
Co-Diagnostics says its COVID tests effective vs. omicron variant
Utah-based molecular diagnostics firm Co-Diagnostics has confirmed that its existing line of COVID-19 polymerase chain reaction diagnostics remain effective...
Co-Diagnostics touts COVID-19 test kit results
Molecular diagnostics company Co-Diagnostics announced that its SARS-CoV-2 saliva test achieved "complete concordance" with commercially available polymerase...

Copyright © 2022 LabPulse.com

Last Updated mp 4/19/2022 12:36:56 PM